BCG
TMO icon

Breakwater Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Breakwater Capital Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$376K Sell
557
-13
-2% -$7.72K 0.04% 290
2026
Q2 		$286K Sell
570
-818
-59% -$393K 0.03% 316
2026
Q1 		$682K Buy
1,388
+810
+140% +$440K 0.09% 199
2025
Q4 		$335K Sell
578
-20
-3% -$11.3K 0.05% 280
2025
Q3 		$290K Hold
598
– – 0.04% 293
2025
Q2 		$242K Sell
598
-362
-38% -$151K 0.04% 309
2025
Q1 		$478K Buy
960
+307
+47% +$166K 0.09% 209
2024
Q4 		$340K Buy
653
+53
+9% +$29.1K 0.07% 216
2024
Q3 		$371K Buy
600
+23
+4% +$13.6K 0.07% 207
2024
Q2 		$319K Buy
577
+38
+7% +$21.8K 0.07% 211
2024
Q1 		$313K Buy
539
+14
+3% +$7.86K 0.08% 201
2023
Q4 		$291K Buy
525
+62
+13% +$30K 0.08% 196
2023
Q3 		$204K Buy
+463
New +$247K 0.07% 207
2023
Q2 		– Sell
-371
Closed -$214K – 206
2023
Q1 		$214K Buy
+371
New +$209K 0.09% 177

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Breakwater Capital Group's TMO Position: Q3 2026 in Review

Breakwater Capital Group reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q3 2026, selling an estimated $7.72K and leaving 557 shares worth $376K. The position accounts for 0.04% of the portfolio, ranked #290.

Breakwater Capital Group first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $682K in Q1 2026. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Breakwater Capital Group held 557 shares of Thermo Fisher Scientific worth $376K as of Q3 2026.
  • Breakwater Capital Group sold 13 Thermo Fisher Scientific shares in Q3 2026, an estimated $7.72K.
  • Thermo Fisher Scientific made up 0.04% of Breakwater Capital Group's portfolio in Q3 2026, its #290 holding.
  • Breakwater Capital Group first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Breakwater Capital Group's Thermo Fisher Scientific position peaked at $682K in Q1 2026.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Breakwater Capital Group's 13F filing for Q3 2026, filed 9 Oct 2026.